Arrowhead Pharmaceuticals Inc (ARWR)
EBITDA Growth
0.54%
Quarterly · Period ending:
ARWR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported0.54%period ending
Latest reported0.54%period ending
ARWR Quarterly EBITDA YoY % (-200.00% → 0.54%)
Year-over-year change
High-resolution chart · PNG
ARWR ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 26.4585% | |
| -1.3871% | |
| -6.9834% | |
| 67.2213% | |
| -103.4034% | |
| 21.9% | |
| -54.295% | |
| -300% | |
| 6,300% | |
| -200% |